Avita Medical | Passività Correnti

Current Liabilities Cambiamento Data
Adcock Ingram Holdings ZAR 2.44B 10.57M 2023-12
Celltrion KRW 250.47B 2.22T 2024-03
Clinuvel Pharmaceuticals AUD 29.39M 3.89M 2023-12
Cochlear AUD 517.4M 60.6M 2023-12
CSL USD 4.72B 110M 2023-12
Cspc Pharmaceutical CNY 10.18B 1.16B 2023-12
Dianthus Therapeutics USD 8.96M 672K 2024-03
Ecofibre AUD 21.58M 15.12M 2023-12
Kangmei Pharma CNY 4.63B 519.86M 2024-03
Knight Therapeutics CAD 116.48M 2.46M 2024-03
Laboratorios Farma EUR 191.25M 8.6M 2024-03
Malin Corporation EUR 1000K 300K 2023-12
Mayne Pharma AUD 310.96M 97.93M 2023-06
Medical Developments International AUD 11.16M 4.39M 2023-12
Nanosonics AUD 28.42M 4.61M 2023-12
Neuren Pharmaceuticals AUD 42.76M 36.75M 2023-12
Opthea USD 32.59M 13.85M 2023-12
Organigram Holdings CAD 56.03M 18.57M 2024-03
Pacific Edge NZD 7.07M 1.2M 2023-09
Paradigm Biopharmaceuticals AUD 10.92M 2.12M 2023-12
Pharma Mar EUR 92.27M 3.62M 2024-03
Polynovo AUD 14.03M 1.36M 2023-12
Probiotec AUD 46M 47.7M 2023-12
PYC Therapeutics AUD 8.63M 225.78K 2023-12
Qiagen NV USD 1.03B 54.13M 2024-03
Ramsay Health Care AUD 3.68B 134.3M 2023-12
ResMed USD 773.03M 8.96M 2024-03
Sartorius EUR 1.37B 42.8M 2024-03
Sino Biopharmaceutical CNY 22.61B 4.26B 2023-12
Telix Pharmaceuticals AUD 157.41M 14.78M 2023-12
Tilray USD 329.1M 65.89M 2024-02
Zz Pientze Pharmaceu 2.26B 708M 2023-09



Avita Medical Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jun 2024.